| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028320 |
| Receipt No. | R000032414 |
| Scientific Title | The influence of vegetable juice intake on blood and skin carotenoid levels. |
| Date of disclosure of the study information | 2017/09/01 |
| Last modified on | 2021/07/26 (Ver. 5) |
| Basic information | ||
| Public title | The influence of vegetable juice intake on blood and skin carotenoid levels. | |
| Acronym | The influence of vegetable juice intake on blood and skin carotenoid levels. | |
| Scientific Title | The influence of vegetable juice intake on blood and skin carotenoid levels. | |
| Scientific Title:Acronym | The influence of vegetable juice intake on blood and skin carotenoid levels. | |
| Region |
|
|
| Condition | |||
| Condition | Not applicable | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Clarify the correlation among vegetable intake and blood carotenoid concentration and skin carotenoid level. |
| Basic objectives2 | Others |
| Basic objectives -Others | Vegetable intake, Blood carotenoid concentration and Skin carotenoid level. |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Vegetable intake(after pre-treatment observation period, after treatment observation period, after post-treatment observation period), blood carotenoid concentration(before and after pre-treatment observation period, 2weeks and 4weeks later of treatment observation period, 2weeks and 4weeks later of post-treatment observation period), skin carotenoid level(before and after pre-treatment observation period, 2weeks and 4weeks later of treatment observation period, 2weeks and 4weeks later of post-treatment observation period) |
| Key secondary outcomes | Skin carotenoid level(every measuring day), blood triglyceride concentration(before and after pre-treatment observation period, 2weeks and 4weeks later of treatment observation period, 2weeks and 4weeks later of post-treatment observation period), blood total cholesterol concentration(before and after pre-treatment observation period, 2weeks and 4weeks later of treatment observation period, 2weeks and 4weeks later of post-treatment observation period) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | In 4 weeks pre-treatment observation period, subjects don't change their dietary habits. In 4 weeks treatment observation period, subject takes 200mL of vegetable juice everyday. In 4 weeks post-treatment observation period, subjects don't change their dietary habits. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Those who are healthy adult men and women and have obtained informed consent | |||
| Key exclusion criteria | 1.Those who routinely take vegetable juices equal to or more than the same amount (200 mL) as the test food.
2.Food allergy to test food. 3.Those who of alcohol hypersensitivity which makes alcohol disinfection difficult. 4.Those who planning to become pregnant or lactating during the examination period. 5.Those who participate in other human tests involving intake of foods rich in carotenoid at the start of this study. 6.Those who judged that the investigator's doctor is inappropriate. |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kagome Co.Ltd. | ||||||
| Division name | Innovation division, Nature&Wellness research department | ||||||
| Zip code | 3292762 | ||||||
| Address | Nishitomiyama 17, Nasushiobara city, Tochigi prefecture | ||||||
| TEL | 0287-36-2935 | ||||||
| Satoshi_Sunabori@kagome.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kagome Co.Ltd. | ||||||
| Division name | Innovation division, Nature&Wellness research department | ||||||
| Zip code | 3292762 | ||||||
| Address | Nishitomiyama 17, Nasushiobara city, Tochigi prefecture | ||||||
| TEL | 0287-36-2935 | ||||||
| Homepage URL | |||||||
| Hiroki_Hayashi@kagome.co.jp | |||||||
| Sponsor | |
| Institute | Kagome Co.Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kagome Co.Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kagome research ethics committee |
| Address | 3-21-1 Nihonbashihamacho, Chuo, Tokyo |
| Tel | 03-5623-8501 |
| Takuji_Hayakawa@kagome.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | カゴメ株式会社イノベーション本部(栃木県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://doi.org/10.3390/diseases9010004 |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | https://doi.org/10.3390/diseases9010004 | ||||||
| Number of participants that the trial has enrolled | 26 | ||||||
| Results | Cross-sectional analysis showed a significant positive correlation between Cutaneous Carotenoid Level (CCL) and vegetable intake. Vegetable juice consumption significantly increased CCL and the blood levels of alpha-carotene, beta-carotene, and lycopene. | ||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | Healthy adults | ||||||
| Participant flow | Subjects measure their skin everyday during experiment period. In the central 4 weeks of the experiment period, subjects drink a carton of vegetable juice everyday. Collection of blood has held 6 times during the period for blood carotenoid analysis. | ||||||
| Adverse events | NA | ||||||
| Outcome measures | Cutaneous carotenoid level, Blood carotenoid concentration, Dietary and living habit. | ||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000032414 |